Trade Summary

5 days ago, Coastlands Capital LP, serving as 10% owner Owner at Pasithea Therapeutics Corp. (KTTA), purchased 100,000 shares at $0.53 per share, for a total transaction value of $53,000.00. Following this transaction, Coastlands Capital LP now holds 3,835,035 shares of KTTA.

This purchase represents a 2.68% increase in Coastlands Capital LP's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, June 17, 2026 and publicly disclosed via SEC Form 4 filing on Monday, June 22, 2026 at 10:30 AM ET, 5 days after the trade was made.

Pasithea Therapeutics Corp. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.